Naratriptan Accord Healthcare (Naratriptan Hydrochloride)

Naratriptan works by selectively activating serotonin 5‑HT1B and 5‑HT1D receptors located on cranial blood vessels and trigeminal nerve endings. This activation causes constriction of dilated intracranial vessels and blocks the release of inflammatory neuropeptides, interrupting the migraine pain pathway.

The exact dose of naratriptan is determined by the prescribing healthcare professional based on the patient’s medical history, severity of migraine, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for naratriptan in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naratriptan has a relatively long half‑life compared with some other triptans, which can provide a more sustained effect for prolonged migraine attacks. Its selectivity for 5‑HT1B/1D receptors is similar to other agents, but individual response and tolerability may vary, so clinicians often choose based on patient history and side‑effect profile.

Store Naratriptan tablets at ambient temperature, preferably below 25 °C. Keep the medication in its original container, protect it from moisture and direct light, and ensure the packaging is tightly closed to maintain stability throughout its shelf life.

Naratriptan is taken orally as a tablet. The patient should swallow the tablet whole with a glass of water, preferably as soon as migraine symptoms begin. It is not intended for prophylactic use and should be taken only when a migraine attack occurs.

The most serious risks include coronary artery spasm or myocardial ischemia, particularly in patients with underlying cardiovascular disease, and serotonin syndrome when combined with other serotonergic drugs. Prompt medical attention is required if chest pain, severe tightness, or signs of serotonin excess develop.

Naratriptan should be avoided in patients with a history of coronary artery disease, uncontrolled hypertension, peripheral vascular disease, or severe hepatic impairment. It is also contraindicated in individuals who have taken other triptans, ergotamine derivatives, or monoamine oxidase inhibitors within the past 24 hours.